Laura Lynne Stockton

Array ( [id] => 5172492 [patent_doc_number] => 20070072925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Amino-5-[4-(difluoromehtoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase' [patent_app_type] => utility [patent_app_number] => 11/526511 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34069 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072925.pdf [firstpage_image] =>[orig_patent_app_number] => 11526511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 174026 [patent_doc_number] => 07659405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Polymorph of a pharmaceutical' [patent_app_type] => utility [patent_app_number] => 11/524972 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6306 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659405.pdf [firstpage_image] =>[orig_patent_app_number] => 11524972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101922 [patent_doc_number] => 20070185184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Carbazole derivatives' [patent_app_type] => utility [patent_app_number] => 11/532340 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21494 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185184.pdf [firstpage_image] =>[orig_patent_app_number] => 11532340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142708 [patent_doc_number] => 20070004924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'SYNTHESIS OF DIARYL PYRAZOLES' [patent_app_type] => utility [patent_app_number] => 11/470689 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12784 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004924.pdf [firstpage_image] =>[orig_patent_app_number] => 11470689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 260197 [patent_doc_number] => 07572924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Pyrrole substituted 2-indolinone protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/517529 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66252 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572924.pdf [firstpage_image] =>[orig_patent_app_number] => 11517529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196369 [patent_doc_number] => 07635774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Benzimidazole derivatives' [patent_app_type] => utility [patent_app_number] => 11/513614 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26342 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635774.pdf [firstpage_image] =>[orig_patent_app_number] => 11513614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005771 [patent_doc_number] => 20070203344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'SYNTHESIS OF IMIDAZOLE 2-THIONES VIA THIOHYDANTOINS' [patent_app_type] => utility [patent_app_number] => 11/468187 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10045 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203344.pdf [firstpage_image] =>[orig_patent_app_number] => 11468187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4683075 [patent_doc_number] => 20080249301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Regioselective Process for Preparing Benzimidazole Thiophenes' [patent_app_type] => utility [patent_app_number] => 12/065655 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86615 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249301.pdf [firstpage_image] =>[orig_patent_app_number] => 12065655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643471 [patent_doc_number] => 20060281926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Synthesis of 2-alkylcysteine via phase transfer catalysis' [patent_app_type] => utility [patent_app_number] => 11/508679 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6525 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281926.pdf [firstpage_image] =>[orig_patent_app_number] => 11508679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4806 [patent_doc_number] => 07816542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Compounds and compositions as TPO mimetics' [patent_app_type] => utility [patent_app_number] => 12/063350 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9840 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816542.pdf [firstpage_image] =>[orig_patent_app_number] => 12063350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753296 [patent_doc_number] => 20080161371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Modulators of cystic fibrosis transmembrane conductance regulator' [patent_app_type] => utility [patent_app_number] => 11/503449 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34469 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161371.pdf [firstpage_image] =>[orig_patent_app_number] => 11503449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216485 [patent_doc_number] => 08629285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Imidazole compounds that modulate HSP90 activity' [patent_app_type] => utility [patent_app_number] => 11/502347 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43033 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11502347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107792 [patent_doc_number] => 20070066670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Substituted benzimidazoles and their use for inducing apoptosis' [patent_app_type] => utility [patent_app_number] => 11/501648 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14617 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066670.pdf [firstpage_image] =>[orig_patent_app_number] => 11501648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228935 [patent_doc_number] => 07601748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Anti-androgenic pyrrolidines with tumor-inhibiting action' [patent_app_type] => utility [patent_app_number] => 11/500876 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18284 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601748.pdf [firstpage_image] =>[orig_patent_app_number] => 11500876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890168 [patent_doc_number] => 20060276526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Crystalline Form of Telmisartan Sodium' [patent_app_type] => utility [patent_app_number] => 11/462531 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4573 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276526.pdf [firstpage_image] =>[orig_patent_app_number] => 11462531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625957 [patent_doc_number] => 20060264462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Imidazolamino compounds' [patent_app_type] => utility [patent_app_number] => 11/495044 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6171 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264462.pdf [firstpage_image] =>[orig_patent_app_number] => 11495044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263831 [patent_doc_number] => 07569596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Imidazolamino compounds' [patent_app_type] => utility [patent_app_number] => 11/494917 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6197 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569596.pdf [firstpage_image] =>[orig_patent_app_number] => 11494917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373481 [patent_doc_number] => 07473784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/494234 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22156 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473784.pdf [firstpage_image] =>[orig_patent_app_number] => 11494234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823253 [patent_doc_number] => 20080227783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => '5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/996743 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13832 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227783.pdf [firstpage_image] =>[orig_patent_app_number] => 11996743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142574 [patent_doc_number] => 20070004790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Nonsedating Alpha-2 Agonists' [patent_app_type] => utility [patent_app_number] => 11/458731 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10218 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004790.pdf [firstpage_image] =>[orig_patent_app_number] => 11458731 [rel_patent_id] =>[rel_patent_doc_number] =>)